Basics Kiniksa Pharmaceuticals, Ltd. IPO Date: May 21, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.04B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.76% Avg Daily Range (30 D): $0.59 | 2.27% Avg Daily Range (90 D): $0.45 | 1.99% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .54M Avg Daily Volume (90 D): .5M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 1,350 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $1.76M Avg Inst. Trade (90 D): $1.81M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.51M Avg Closing Trade (30 D): $2.05M Avg Closing Trade (90 D): $1.52M Avg Closing Volume: 82.92K     News Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights Feb 20, 2025 @ 9:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter a... Source: N/A Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.24 $.12 $-.12 Diluted EPS $-.25 $.11 $-.12 Revenue $ 481.17M $ 137.79M $ 122.54M Gross Profit $ 412.97M $ 119.92M $ 104.64M Net Income / Loss $ -16.95M $ 8.54M $ -8.89M Operating Income / Loss $ -15.8M $ 13.27M $ -19.3M Cost of Revenue $ 68.2M $ 17.87M $ 17.9M Net Cash Flow $ 16.05M $ -26.45M $ 86.21M PE Ratio